These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8394063)

  • 1. [Concurrent daily low-dose cisplatin combined with chest irradiation in advanced non-small cell lung cancer].
    Fujii S; Hamamoto Y; Sugai Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1397-9. PubMed ID: 8394063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
    Nakano K; Kumagai K; Ishida H; Kohjima N; Hiramoto T; Hada Y
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):57-61. PubMed ID: 8546470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer].
    Sato T; Mitsuhata N; Fujiwara K; Miyake M; Jyojya I; Ono T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):719-22. PubMed ID: 2451474
    [No Abstract]   [Full Text] [Related]  

  • 5. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
    Yano T; Koga T; Nomiyama H; Hidaka H
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
    Kubota K
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
    Comella G; Frasci G; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Ruffolo P; Comella P
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.
    Winterhalder R; Deschler-Marini S; Landmann C; Kann R; Passweg J; Herrmann R; Pless M
    Radiother Oncol; 2004 Dec; 73(3):321-4. PubMed ID: 15588877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial of combined radiotherapy and low-dose carboplatin for non-small cell lung cancer].
    Kaneko T; Okagawa K; Mizunoya S; Nishiyama K; Ikeda T; Ito M
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1401-3. PubMed ID: 8394064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer.
    Cakir S; Egehan I
    Lung Cancer; 2004 Mar; 43(3):309-16. PubMed ID: 15165089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer.
    Ulutin HC; Güden M; Oysul K; Sürenkök S; Pak Y
    Radiat Med; 2000; 18(2):93-6. PubMed ID: 10888041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
    Vokes EE; Leopold KA; Herndon J; Green MR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality management of regionally advanced non-small-cell lung cancer.
    Belani CP
    Semin Oncol; 1993 Aug; 20(4):302-14. PubMed ID: 8393590
    [No Abstract]   [Full Text] [Related]  

  • 16. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
    Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer.
    Schild SE; Wong WW; Vora SA; Halyard MY; Northfelt DW; Kogut HL; Wheeler RH
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1432-7. PubMed ID: 16029804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS; Yoon SM; Choi EK; Yi BY; Kim JH; Ahn SD; Lee SW; Shin SS; Lee JS; Suh C; Kim SW; Kim DS; Kim WS; Park HJ; Park CI
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):76-81. PubMed ID: 15850905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.